Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges
Jeffrey Glennon(University College Dublin), Jan K. Buitelaar(Radboud University Nijmegen), Marina Danckaerts(KU Leuven), Bruno Falissard(Inserm), Sara Carucci(University of Cagliari), María José Penzol(Hospital General Universitario Gregorio Marañón), Pieter J. Hoekstra(University Medical Center Groningen), Ulrike Schulze(MRC Laboratory of Molecular Biology), Mireille J. Bakker, Gabriele Masi(Fondazione Stella Maris), Alessandro Zuddas(University of Cagliari), Diane Purper‐Ouakil(Inserm), Paramala Santosh(King's College London), Macey L. Murray(MRC Clinical Trials Unit at UCL), Josefina Castro‐Fornieles(Hospital Clínic de Barcelona), Regina Dittmann(Forschungszentrum Jülich), Itziar Flamarique(Centro de Investigación Biomédica en Red de Salud Mental), David Coghill(The University of Melbourne), Ian Chi Kei Wong(Blacktown & Mount Druitt Hospital), Olivier Bonnot, Stefano Vicari(Bambino Gesù Children's Hospital), Michael Kölch(Universität Ulm), Celso Arango(Hospital Universitario La Paz), Jörg M. Fegert(Universität Ulm), Mandy Wan(King's College London)
Cited by 33
Related Papers
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders
|Cell|2019|1.5k
The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder
|Neuroscience & Biobehavioral Reviews|2021|1.4k
Attention-deficit/hyperactivity disorder
|Nature Reviews Disease Primers|2015|1.3k
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data
|Brain Imaging and Behavior|2014|884